Domma Secures €950,000 for Menopause Research and Solutions

Domma, a Barcelona-based startup focused on menopause research, treatment, and support, has recently secured €950,000 in funding, comprising both equity and debt components. This funding round, led by Secways and supported by Antai Ventures, as well as strategic business angels and ENISA, is aimed at advancing scientific research initiatives and developing innovative biotechnological solutions to improve women's health during the menopausal transition. Co-founders Cristina Martínez and Mireia Roca intend to utilize the raised capital to accelerate the digitalization of menopausal support services and expand their consumer outreach efforts.

Cristina Martínez, one of the founders of Domma, emphasized the startup's commitment to destigmatizing menopause and providing personalized support tailored to individual needs. She highlighted the importance of offering solutions that address the unique challenges faced by women during this transitional phase, aligning with Domma's mission to enhance the quality of life for women experiencing menopause.

Secways and Antai Ventures, the primary investors in Domma's recent funding round, commended the startup's leadership and its mission-driven approach. They recognized Domma's potential to make a significant impact in the lives of women navigating menopause by offering innovative solutions and comprehensive support. This endorsement reflects investors' confidence in Domma's ability to drive positive change and contribute to the advancement of women's health.

Domma's product portfolio includes a range of scientifically validated natural alternatives designed to address hormonal and emotional imbalances. These offerings include superfood and adaptogen blends for hormonal regulation, nutritional supplements promoting libido and sexual well-being, intimate serums, sleep improvement supplements, and relaxing herbal teas.

Domma has experienced substantial growth and engagement within its community, with over a thousand subscribers to its personalized treatment and support plans. The startup achieved an impressive 350% growth in 2023, marking its second year of operation, and has cultivated a community of over 100,000 women engaged in discussions related to climacteric and mature female health.

Domma  boasts a dedicated team of ten seasoned professionals who are at the forefront of revolutionizing women's health. Drawing on their collective expertise and driven by a passion for innovation, Domma is primed for substantial growth and influence in this critical field. With a solid foundation built on unwavering commitment, Domma is well-positioned to lead the charge in addressing the multifaceted challenges faced by women during menopause. Their relentless pursuit of groundbreaking solutions underscores their commitment to improving the quality of life for women worldwide, setting the stage for continued success and advancements that will redefine the landscape of women's health care.